1. Execution of the CDA between the sponsor, PI and VA.
2. Agreement that the VA will serve as a site for the specific corporate sponsored trial/research
3. The appropriate CRADA model is supplied
to the sponsor. The sponsor’s legal team
reviews the CRADA model and makes changes
(with track changes ‘on’) and returns to the
Executive Director (ED) of the Biomedical
Research Foundation.
4. The ED reviews the sponsor’s edits and
passes the redlined CRADA on to the
appropriate VA STAR attorney.
5. The CRADA negotiations continue until
there is a meeting of the minds.
6. CRADA is executed by having all
parties (sponsor, PI, ED and Medical
Center Director) sign STAR attorney
approved CRADA.
Approximately 2 months turnaround
time if sponsor is timely with CRADA edits.
3B. Study budget is submitted by sponsor
to research coordinator.
4B. The ED and the research coordinator
discuss the budget and provide the sponsor
with any necessary changes based on BRF
CRADA contracting fee structure and projected
costs for per patient visit specific procedures.
5B. Budget negotiations continue until there is
a meeting of the minds.
6B. Final budget gets incorporated into
approved CRADA.
Approximately 1-2 months of turnaround time.
3A. The research coordinator completes
the IRB package that is pre-reviewed by
one member of the IRB committee.
Comments and suggestions are passed
back to the coordinator.
4A. The research coordinator submits a
completed package to IRB for a full
committee review (The VA IRB meets
twice monthly).
5A. If not approved on the first
submission, the IRB provides
contingencies that must be addressed
with the package to be resubmitted
for a second review.
6A. Once the IRB has approved, the
project is then submitted to the VA’s
R&D committee for approval (which also
meets twice per month).
Approximately 2-2.5 months turnaround
time for IRB with an additional 0.5-1
month for R&D approval.